https://diabetessociety.com.au/documents/2018_ALERT-ADS_SGLT2i_PerioperativeKetoacidosis_v3__final2018_02_14.pdf
Another link here to the Australian diabetes society showing concern about SGLT2 inhibitors. (Pdf format in the link)
Did you come across this too, Singhgu? How do you think DMX200 may compare to the SGLT2 treatments?
DMX200 competition including SGLT2 Inhibitors, page-5
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
0.015(3.95%) |
Mkt cap ! $220.0M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 40.5¢ | 37.0¢ | $863.2K | 2.230M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 56796 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 15592 | 1 |
View Market Depth
| Last trade - 15.59pm 08/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |